In the company’s news yesterday,
China Jo-Jo Drugstores Inc. announced its financial results for the third quarter ended December 31, 2009, posting increases in revenues, gross profit and income from operations.
The company posted revenues at $14.9 million, up 29.1 percent from the year prior, which the company attributes to a boost in same-store sales and quality products.
“Our revenue increase in the fiscal third quarter ended December 31, 2009, was largely attributable to operating more stores and increasing overall same store sales,” Lei Liu, chairman and CEO of Jo-Jo Drugstores stated in the press release. “Throughout the quarter, we continued to execute on our goal of providing our customers with quality name brand products at the lowest overall prices and offering physician consultations at all of our locations. Our focus is our customer’s overall health.”
Gross profit for the fiscal third quarter rose 43.4 percent to $4.8 million, as compared to the third quarter of 2008. Gross margin for the quarter was 31.9 percent, compared with 28.8 percent in the comparable 2008 period.
The company reported income from operations at $3.4 million for the third fiscal quarter of 2009, accounting for 22.9 percent of revenues, up from $2.7 million, or 23.6 percent of revenues, for the same quarter in 2008.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
